10-K: Privia Health Reports Strong 2025 Growth, Doubles Operating Income

Privia Health Group, Inc. announced significant financial and operational growth for the year ended December 31, 2025, driven by increased provider base and value-based care expansion.

Summary

• Revenue for the year ended December 31, 2025, increased by 22.3% to $2.12 billion, up from $1.74 billion in 2024.
• Operating income more than doubled, rising 101.6% to $34.2 million in 2025 from $17.0 million in 2024.
• Net income attributable to Privia Health Group, Inc. increased 59.3% to $22.9 million in 2025, compared to $14.4 million in 2024.
• The number of implemented providers grew by 12.3% to 5,380 as of December 31, 2025, from 4,789 in 2024.
• Attributed lives in value-based care arrangements increased by 22.7% to 1.54 million as of December 31, 2025, from 1.26 million in 2024.
• Practice Collections rose 16.9% to $3.47 billion in 2025, up from $2.97 billion in 2024.
• Adjusted EBITDA increased 38.8% to $125.5 million in 2025, compared to $90.5 million in 2024.
• The company expanded into new markets in Arizona and Florida through acquisitions in 2025, and acquired an ACO business from Evolent Health, Inc., adding over 120,000 attributed lives.
• Privia Health's ACOs achieved $233.1 million in shared savings in 2024, a 32% increase over 2023, with per capita expenditures 8% lower than the median MSSP ACO.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this filing as highly positive, reflecting robust financial and operational growth, particularly in key metrics like revenue, operating income, and value-based care attributed lives. The strategic acquisitions and strong performance in shared savings programs underscore a solid execution of its growth strategy, despite a slight dip in cash due to these investments.

Positives

• Total revenue increased by 22.3% to $2.12 billion in 2025, demonstrating strong top-line growth.
• Operating income surged by 101.6% to $34.2 million, indicating improved operational efficiency and profitability.
• Net income attributable to Privia Health Group, Inc. grew by 59.3% to $22.9 million, reflecting enhanced shareholder value.
• Adjusted EBITDA increased by 38.8% to $125.5 million, highlighting robust underlying business performance.
• The implemented provider base expanded by 12.3% to 5,380, indicating successful provider recruitment and retention.
• Attributed lives in value-based care arrangements increased by 22.7% to 1.54 million, signaling strong adoption and growth in VBC models.
• Shared savings revenue increased by 31.0% to $234.8 million, driven by more attributed lives in Medicare programs and strong performance in VBC.
• Capitated revenue increased by 44.8% to $308.5 million, primarily due to increased attributed lives and improved contract terms.
• The company successfully entered new markets in Arizona and Florida and acquired an ACO business, expanding its geographic footprint and VBC capabilities.

Negatives

• The company has a history of net losses and an accumulated deficit, though net income was positive in 2025.
• Cash and cash equivalents decreased from $491.1 million in 2024 to $479.7 million in 2025, primarily due to significant business acquisitions.
• The company is highly dependent on its EMR vendor, athenahealth, Inc., and disruptions or changes to this relationship could adversely affect operations.
• Care Margin as a percentage of revenue decreased to 21.8% in 2025 from 23.3% in 2024, despite strategic investments.

Risks

• Operating in a heavily regulated industry, with potential for financial penalties, exclusion from government healthcare programs, or required business model changes due to non-compliance with healthcare laws and regulations (e.g., Anti-Kickback Statute, Stark Law, HIPAA).
• Reliance on a complex legal framework governing relationships with Medical Groups and Privia Providers, with legal challenges or shifting interpretations potentially requiring significant operational changes.
• Adverse effects from changes and uncertainty in the healthcare industry, including health reform initiatives (e.g., ACA, OBBBA, price transparency, No Surprises Act) and increased judicial scrutiny of federal agency actions.
• Exposure to legal proceedings, governmental investigations, claims, and payer audits, which could result in significant settlement costs, judgments, penalties, or reputational harm.
• Risks associated with Value-Based Care (VBC) arrangements, including managing targets, fluctuations in payment terms, changes in patient attribution, regulatory changes, and the potential for reduced reimbursement or repayment obligations if performance standards are not met.
• Reductions in reimbursement rates from federal or state healthcare programs or commercial payers, or an inability to negotiate favorable contracts, could lead to declining revenues.
• The complexity and potential delays in the reimbursement process, including uncertainties under FFS and VBC models, could adversely affect cash flows and revenues.
• Inaccurate, incomplete, or unsupportable information provided to Medicare Advantage plans and other payers could impact risk adjustment scores, leading to repayment obligations or liability under fraud and abuse laws.
• Third-party payer controls (including AI-driven utilization review) designed to reduce costs and utilization could reduce revenues.
• Intense competition in the highly fragmented U.S. healthcare industry from various providers and emerging companies, potentially impacting the ability to attract and retain talent, patients, and payer contracts.
• Failure to continuously innovate and evolve service offerings, including the use of AI, to meet technological developments and sophisticated physician, payer, and patient requirements.
• Long and unpredictable sales and implementation cycles for new providers, potentially leading to fluctuating results and substantial upfront costs.
• Inability to efficiently price the Privia Technology Solution, Privia Platform, and operating model, which could affect results of operations and ability to attract/retain partners.
• Challenges in executing the growth strategy, including contracting with payers, recruiting/retaining providers, expanding into new markets, and integrating acquisitions.
• Difficulties in integrating acquired entities or assets, realizing expected results, or becoming liable for unknown or contingent liabilities from acquisitions.
• Dependence on third-party vendors, particularly athenahealth, Inc. for EMR, and risks associated with service disruptions, price increases, or compliance failures by these vendors.
• Security threats, cybersecurity incidents, data breaches, or other disruptions to information technology systems, potentially compromising sensitive information, harming patients, and leading to liability or reputational damage.
• Inability to protect intellectual property (trademarks, trade secrets, copyrights) or allegations of infringing third-party intellectual property rights, which could harm competitive position and financial results.
• Restrictions on the use or licensing of data, or failure to integrate third-party technologies, could adversely affect business operations.
• Risks associated with the use of open-source software, including potential litigation or requirements to disclose proprietary code.
• Challenges related to healthcare technology initiatives, including patient data sharing, interoperability, and the use of AI and machine learning models, which may lead to new regulatory scrutiny or compliance obligations.
• Compliance with HIPAA and other federal/state privacy and security regulations, with actual or perceived failures potentially resulting in significant liability or reputational harm.
• Dependence on the senior management team and other key employees, with the loss of such personnel or inability to attract/retain qualified talent (including physicians) potentially harming the business.
• Inability to maintain corporate culture as the company grows, potentially leading to a loss of innovation, creativity, and teamwork.
• History of net losses and anticipated increasing expenses, with no assurance of maintaining profitability.
• Limitations on the ability to utilize net operating losses (NOLs) to offset future taxable income due to Section 382 of the Internal Revenue Code.
• Risks associated with indebtedness, including restrictive covenants in the Revolving Credit Agreement and potential for increased borrowing costs due to interest rate fluctuations.
• Failure to raise additional capital or generate sufficient cash flows in the future could limit operational flexibility and growth prospects.
• Failure to maintain effective internal control over financial reporting, which could adversely affect investor confidence and lead to litigation or investigations.
• Deterioration of public health conditions (e.g., pandemics) could adversely impact business operations, patient volumes, and financial condition.
• Increased attention to ESG initiatives could lead to higher costs, enhanced compliance obligations, or reputational harm.
• Provisions in corporate governance documents (e.g., classified board, no stockholder action by written consent) could make an acquisition more difficult and prevent stockholders from replacing management.
• Stock price volatility due to market conditions, operating results fluctuations, competitive actions, regulatory developments, and other factors.
• Future sales and issuances of common stock could cause the market price to drop significantly.
• No current plans to pay regular cash dividends, meaning return on investment is solely dependent on stock price appreciation.

Future Outlook

The company's growth strategy is centered on capturing opportunities in existing markets and entering multiple new markets nationally over the next decade. This includes organic growth through enhanced patient experience, new provider recruitment, and expanded services, as well as increasing revenue from value-based care contracts. The company plans to continue investing in its technology-enabled platform, sales and marketing, and operations to support this expansion and transition markets towards value-based care models.

Management Comments

• The Annual Report on Form 10-K does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made not misleading.
• The financial statements and other financial information included in this report fairly present in all material respects the financial condition, results of operations, and cash flows of the registrant.
• Management is responsible for establishing and maintaining disclosure controls and procedures and internal control over financial reporting, which were evaluated as effective as of December 31, 2025.

Industry Context

StockSavvy.ai notes that Privia Health operates within a U.S. healthcare system undergoing a significant macro shift towards value-based care (VBC) models, which prioritize coordinated, high-quality care at lower total costs. This trend is driven by rising healthcare expenditures, projected to reach $8.6 trillion or 20.3% of GDP by 2033, and the inherent inefficiencies of the traditional fee-for-service model. Physicians continue to face challenges with declining profitability, administrative burdens, and complex payment models, making physician enablement platforms like Privia's increasingly relevant. The industry is highly competitive and fragmented, with ongoing consolidation among payers and providers, and the emergence of new technologies, including AI, intensifying the need for modernized care models.

Comparison to Industry Standards

• In 2024, Privia's nine Accountable Care Organizations (ACOs) achieved $233.1 million in shared savings through the Medicare Shared Savings Program (MSSP), representing a 32% increase over 2023, significantly outperforming many peers.
• Privia's per capita expenditures per member per year were 8% lower than the median MSSP ACO and 22% lower than total Fee-for-Service (FFS) Medicare, demonstrating superior cost management compared to industry averages.
• Weighted average realized emergency department visits for Privia's ACOs were 17% lower than the median MSSP ACO and 25% lower than total FFS Medicare, indicating effective patient care coordination and reduced unnecessary utilization.
• Weighted average outpatient facility spend was 23% lower than the median MSSP ACO and 35% lower than total FFS Medicare, showcasing efficiency in outpatient care delivery.
• Weighted average inpatient facility spend was 13% lower than the median MSSP ACO and 28% lower than total FFS Medicare, reflecting successful management of high-cost inpatient services.

Corporate Governance

Legal Proceedings

• The company is currently involved in, and may in the future become involved in, legal proceedings, claims, and investigations in the ordinary course of business, including medical malpractice claims.
• Management does not believe that the final outcome of any current matters is reasonably likely to have a material adverse effect on the business, financial condition, or results of operations.

Related Party Transactions

• The company entered into a strategic alignment agreement with ChoiceHealth, Inc. (a subsidiary of Novant Health, Inc.) on March 2, 2023, for a strategic partnership to launch Privia Medical Group North Carolina.
• Under this agreement, Novant Sub is entitled to receive shares of the company's common stock upon achieving certain milestones, such as implementing 1,000 providers in specified markets or entering new states.
• A member of the Board of Directors is also a member of the board of trustees of Novant Health.

Stakeholder Impact

• Shareholders: Potential for continued stock price appreciation due to strong growth, but no cash dividends are anticipated in the foreseeable future. Future stock sales could cause price volatility.
• Employees: Continued investment in talent development, health, and wellness programs, and a flexible workforce strategy aim to attract and retain skilled personnel. Corporate culture is emphasized as a critical success factor.
• Patients: Enhanced patient experience, improved outcomes, and access to coordinated, high-quality care through the Privia Platform and virtual visit capabilities.
• Providers (Physicians and Clinicians): Increased profitability, reduced administrative burden, significant provider autonomy, and access to value-based care opportunities through the Privia Platform and Medical Group model.
• Payers: Collaboration to achieve lower total costs and improved patient outcomes through value-based care arrangements and customized medical benefits packages for employers.
• Creditors: No outstanding debt under the Revolving Credit Facility as of December 31, 2025, indicating a strong liquidity position, but future indebtedness could impose restrictions.

Next Steps

• Continue organic growth in existing practices by increasing patient panels and volumes, recruiting new providers, and expanding practice services.
• Accelerate the transition of markets to value-based care (VBC) programs, aiming to increase attributed patients and enhance revenue opportunities per patient.
• Develop new products and programs in partnership with aligned payers to further VBC adoption.
• Pursue white space opportunities in existing markets by adding primary care and specialist practices, expanding Privia Women's Health and Pediatrics platforms, and developing value-oriented ancillary services.
• Expand relationships with self-insured employers and pursue direct contracting opportunities.
• Continue to develop new markets nationally through a data-driven selection process and strategic partnerships.
• Engage in disciplined and strategic acquisitions and investments, including minority or majority ownership of provider groups or clinically integrated networks.

Key Dates

Recommendation

Privia Health's 2025 performance demonstrates exceptional growth across key financial and operational metrics, including a doubling of operating income and significant increases in revenue, Adjusted EBITDA, implemented providers, and attributed lives. The company's strategic focus on value-based care, successful market expansion through acquisitions, and proven ability to reduce healthcare costs relative to industry benchmarks position it strongly in a growing market. While the company has a history of net losses, the current trajectory towards sustained profitability, coupled with a robust growth strategy and strong cash position, makes it an attractive investment for long-term capital appreciation. The risks associated with regulatory changes and competition are inherent to the healthcare sector but appear to be well-managed by Privia's established platform and governance.

Keywords

Healthcare, Physician Enablement, Value-Based Care, ACO, EMR, Telehealth, Financial Results, SEC Filing, 10-K, Privia Health, PRVA, Medical Group, Patient Care, Revenue Growth, Adjusted EBITDA